SUBSCRIBE
SUBSCRIBE
News   Drug Development

Novartis AG Eyes Rapid H1N1 Vaccine Production

June 12, 2009 | 
1 min read
Bookmark and Share

Reuters -- Novartis AG has produced a first batch of a vaccine to fight the H1N1 flu outbreak, will start clinical trials in July and expects to be able to ramp up manufacture rapidly.

Clinical research Postmarket research
Novartis
MORE ON THIS TOPIC
Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
May 1, 2025
 · 
3 min read
 · 
Heather McKenzie
Conceptual business illustration of upcoming business problem metaphor with falling domino and businessman silhouette. Minimalistic vector eps 10 illustration
Multiple sclerosis
Immunic Talks Up Disability Gains as Phase II MS Therapy Fails on Primary Endpoint
May 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Chicago, Illinois, USA on Lake Michigan at dawn.
Cancer
AACR 2025 Tracker: Merck, GSK, Roche and More Present Key Data
April 30, 2025
 · 
8 min read
 · 
BioSpace Editorial Staff
An obstacle to achieving a goal. Concerns and issues. Break through the refusal barrier. Face problems and challenges.
Prostate cancer
AstraZeneca’s Truqap Posts Another Pivotal Disappointment as Phase III Prostate Cancer Study Fails
April 30, 2025
 · 
2 min read
 · 
Tristan Manalac